Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07000318 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CS-206 in Patients With Sickle Cell Disease

StatusNot Yet Recruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Sep 30, 2027 to Dec 30, 2028
    • Start date: Jun 30, 2025 to Sep 30, 2026
    • Study completion date: Dec 31, 2027 to Mar 31, 2029
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this open label, single-arm clinical study is to learn about the safety and efficacy of CS-206 injection in treating sickle cell disease.
Trial Details
NCT Number NCT07000318
Lead Sponsor Children's Hospital of Fudan University
Conditions
(from sponsor)		 Sickle Cell Disease
Related terms Anemia, Sickle Cell
Enrollment 5 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov